The Centers for Disease Control and Prevention's decision to fold Covid-19 and other respiratory-disease work into its influenza... Read More
Jay Bhattacharya teased new funding opportunities for young and early-career scientists to build public trust in public health. Read More
Last week’s jobs report delivered an unexpectedly strong result: Employers added 162,000 jobs in August. Health care was not responsible... Read More
Most people assume that when they need a doctor, a doctor will be available. Read More
Visiting a doctor is easier when the appointment can take place from home. Since the COVID-19 pandemic, telehealth has become a common option... Read More
Most Favored Nation (MFN) pricing could meaningfully cut federal drug spending, but much of those savings may evaporate as manufacturers... Read More
I have never seen a business advertise itself so heavily with the “Be careful, we might kill you” motto— but that is certainly the case... Read More
An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only... Read More
Andersen denied that his Fauci CREID grant was for biodefense, yet NIH’s own database lists Andersen’s grant under biodefense. Read More
On the rise of political advocacy in medicine and public health, where it leads us astray, what it costs the public, and the case for a... Read More
GLP-1 drugs have redefined the term “pharmaceutical blockbuster”. Already a USD$79 billion global market, continued growth is... Read More
Infantile amnesia is not simply a story about forgetting the past. It is an opportunity to understand how memory itself is built. Read More
The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More
Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More
I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More
If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More
The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More
On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More
This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More
Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More
This is a difficult moment for Roe v. Wade to have fallen.... Read More
If Congress and the administration do not plan and work together, the end of the old emergency will only mark the beginning of a new emergency.... Read More
The Affordable Care Act has faded into the political background since Republicans failed to repeal the entitlement in 2017, but ObamaCare still doesn't work as promised. The Biden Administration said this week that it will throw more money at one problem, and the result will be to hook more Americans on government subsidies. ... Read More
